Literature DB >> 2590616

Bioavailability of intranasal metoclopramide.

M J Ward1, D C Buss, J Ellershaw, A Nash, P A Routledge.   

Abstract

After intranasal administration of metoclopramide, (5 mg in 0.5 ml sterile water) the maximum plasma concentration of 13.5 +/- 7.3 (mean +/- s.d.) ng ml-1 was achieved. Absolute bioavailability was 50.5 +/- 29.5%, 110 +/- 41 min later. We conclude that the intranasal route does not allow rapid absorption of the drug and is not associated with greater bioavailability than the oral route.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590616      PMCID: PMC1380026          DOI: 10.1111/j.1365-2125.1989.tb03552.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.

Authors:  M L Citron; J R Reynolds; J Kalra; B G Kay; K A Nathan; N D Jaffe; F R Miller
Journal:  Cancer Treat Rep       Date:  1987-03

2.  The pharmacokinetics of metoclopramide in man with observations in the dog.

Authors:  D N Bateman; C Kahn; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

3.  Single-dose pharmacokinetics of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; W D Hooper; F Bochner
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

5.  The pharmacokinetics, bioequivalence and bioavailability of different formulations of metoclopramide in man.

Authors:  W Block; A Pingoud; M Khan; P Kjellerup
Journal:  Arzneimittelforschung       Date:  1981
  5 in total
  2 in total

Review 1.  Pharmacokinetic optimisation of antiemetic therapy.

Authors:  M Campbell; D N Bateman
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

Review 2.  Intranasal metoclopramide.

Authors:  D Ormrod; K L Goa
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.